X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (19249) 19249
Book Review (4881) 4881
Publication (1319) 1319
Book / eBook (228) 228
Newsletter (177) 177
Book Chapter (145) 145
Conference Proceeding (108) 108
Newspaper Article (24) 24
Dissertation (13) 13
Magazine Article (4) 4
Paper (4) 4
Transcript (2) 2
Reference (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (16879) 16879
humans (16420) 16420
transplantation (11333) 11333
male (9955) 9955
female (9692) 9692
hematology (9672) 9672
adult (8144) 8144
middle aged (7232) 7232
oncology (6645) 6645
immunology (6080) 6080
stem cells (5398) 5398
hematopoietic stem cell transplantation - adverse effects (5148) 5148
adolescent (5082) 5082
bone-marrow-transplantation (5076) 5076
hematopoietic stem cells (5054) 5054
transplantation, homologous (3996) 3996
treatment outcome (3865) 3865
aged (3633) 3633
child (3608) 3608
hematopoietic stem cell transplantation (3240) 3240
stem-cell transplantation (3228) 3228
risk factors (3058) 3058
retrospective studies (2979) 2979
health aspects (2776) 2776
care and treatment (2724) 2724
young adult (2682) 2682
versus-host-disease (2645) 2645
chemotherapy (2506) 2506
hematopoietic stem cell transplantation - methods (2489) 2489
cancer (2486) 2486
child, preschool (2457) 2457
stem cell transplantation (2419) 2419
transplantation conditioning - methods (2362) 2362
bone marrow (2220) 2220
leukemia (2220) 2220
animals (2186) 2186
research (2052) 2052
bone marrow transplantation (1987) 1987
graft vs host disease - etiology (1980) 1980
hematology, oncology and palliative medicine (1972) 1972
analysis (1894) 1894
therapy (1824) 1824
bone marrow transplantation - adverse effects (1808) 1808
transplantation conditioning - adverse effects (1751) 1751
children (1636) 1636
transplantation, autologous (1628) 1628
prognosis (1617) 1617
infant (1612) 1612
transplantation conditioning (1603) 1603
transplants & implants (1574) 1574
survival analysis (1519) 1519
graft vs host disease - prevention & control (1514) 1514
mortality (1505) 1505
medicine & public health (1461) 1461
bone-marrow transplantation (1431) 1431
recurrence (1425) 1425
follow-up studies (1362) 1362
recipients (1341) 1341
antineoplastic combined chemotherapy protocols - therapeutic use (1294) 1294
disease-free survival (1286) 1286
survival (1259) 1259
hematologic neoplasms - therapy (1245) 1245
diagnosis (1239) 1239
acute myeloid-leukemia (1219) 1219
patient outcomes (1201) 1201
disease (1195) 1195
article (1189) 1189
complications and side effects (1183) 1183
survival rate (1178) 1178
combined modality therapy (1152) 1152
time factors (1145) 1145
pediatrics (1134) 1134
abridged index medicus (1124) 1124
immunosuppressive agents - therapeutic use (1043) 1043
incidence (1041) 1041
blood (1037) 1037
prospective studies (1014) 1014
cyclophosphamide (1006) 1006
acute disease (995) 995
immunotherapy (991) 991
total-body irradiation (985) 985
surgery (955) 955
transplantation, homologous - adverse effects (930) 930
t cells (923) 923
patients (894) 894
risk (881) 881
risk-factors (881) 881
leukemia, myeloid, acute - therapy (865) 865
mice (860) 860
usage (848) 848
tissue donors (844) 844
graft vs host disease - immunology (825) 825
medical research (822) 822
graft survival (817) 817
remission induction (796) 796
unrelated donors (794) 794
graft-versus-host disease (787) 787
prevention (777) 777
relapse (769) 769
medicine, research & experimental (757) 757
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (182) 182
Collection Dvlpm't (Acquisitions) - Closed Orders (21) 21
St. Michael's College (John M. Kelly) - 2nd Floor (14) 14
UofT at Mississauga - Stacks (12) 12
St. Augustine's Seminary - Stacks (11) 11
Online Resources - Online (10) 10
UofT at Scarborough - Stacks (9) 9
UTL at Downsview - May be requested (8) 8
Collection Dvlpm't (Acquisitions) - Vendor file (6) 6
Trinity College (John W Graham) - Stacks (5) 5
Regis College - Stacks (4) 4
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (4) 4
Victoria University E.J. Pratt - Stacks (4) 4
Humber River Regional Hospital - Church Stacks (3) 3
Law (Bora Laskin) - Stacks (3) 3
New College (Ivey) - Stacks (3) 3
Providence Healthcare - Stacks (3) 3
St Josephs Health Centre - Stacks (3) 3
Trinity College (John W Graham) - Wycliffe Storage (3) 3
Engineering & Comp. Sci. - Stacks (2) 2
Knox College (Caven) - Stacks (2) 2
Scarborough Hospital - General (2) 2
St. Augustine's Seminary - Reference (2) 2
Victoria University Emmanuel College - Stacks (2) 2
Baycrest Hospital - Stacks (1) 1
Credit Valley Hospital - Stacks (1) 1
Dentistry (Harry R Abbott) - Stacks (1) 1
Dentistry (Harry R Abbott) - Withdrawn (1) 1
Gerstein Science - Circulation Desk (1) 1
Gerstein Science - Reference (1) 1
Holland Bloorview Kids Rehabilitation - Stacks (1) 1
Mt Sinai Hospital - Pathology (1) 1
New College (Ivey) - Withdrawn (1) 1
OISE - Stacks (1) 1
Providence Healthcare - Reference (1) 1
Providence Healthcare - Withdrawn (1) 1
Regis College - Reference (1) 1
Robarts - Stacks (1) 1
Scarborough Hospital - Birchmount (1) 1
St. Michael's Hospital - Stacks (1) 1
Trinity College (John W Graham) - Reference (1) 1
University College (Laidlaw) - Stacks (1) 1
Victoria University Emmanuel College - Reference (1) 1
Women's College Hospital - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (19441) 19441
Chinese (104) 104
Japanese (69) 69
French (59) 59
Spanish (45) 45
German (32) 32
Polish (14) 14
Czech (9) 9
Italian (8) 8
Russian (7) 7
Korean (6) 6
Portuguese (5) 5
Croatian (3) 3
Dutch (3) 3
Norwegian (3) 3
Swedish (3) 3
Danish (2) 2
Hungarian (2) 2
Slovak (2) 2
Serbian (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Bone Marrow Transplantation, ISSN 0268-3369, 01/2011, Volume 46, Issue 1, pp. 98 - 104
Dyskeratosis congenita (DC) is characterized by reticular skin pigmentation, oral leukoplakia and abnormal nails. Patients with DC have very short telomeres... 
hematopoietic cell transplantation | dyskeratosis congenita | reduced-intensity conditioning regimen | ALEMTUZUMAB | HOYERAAL-HREIDARSSON-SYNDROME | BONE-MARROW-TRANSPLANTATION | ANTITHYMOCYTE GLOBULIN | IMMUNOLOGY | FANCONI-ANEMIA | FLUDARABINE | FAILURE | TRANSPLANTATION | CORD BLOOD TRANSPLANTATION | ONCOLOGY | HEMATOLOGY | APLASTIC-ANEMIA | MELPHALAN | Antibodies, Neoplasm - therapeutic use | Cyclophosphamide - administration & dosage | Peripheral Blood Stem Cell Transplantation - adverse effects | Humans | Antibodies, Monoclonal - adverse effects | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Child, Preschool | Antibodies, Monoclonal - therapeutic use | Male | Antineoplastic Agents - therapeutic use | Antineoplastic Agents - administration & dosage | Cyclophosphamide - adverse effects | Cyclophosphamide - therapeutic use | Whole-Body Irradiation - adverse effects | Young Adult | Antibodies, Monoclonal, Humanized | Cord Blood Stem Cell Transplantation - adverse effects | Antineoplastic Agents - adverse effects | Dyskeratosis Congenita - therapy | Hematopoietic Stem Cell Transplantation - adverse effects | Female | Transplantation Conditioning - adverse effects | Transplantation Conditioning - methods | Pulmonary Fibrosis - etiology | Vidarabine - adverse effects | Vidarabine - analogs & derivatives | Alemtuzumab | Antibodies, Neoplasm - administration & dosage | Vidarabine - therapeutic use | Combined Modality Therapy - adverse effects | Dyskeratosis Congenita - physiopathology | Antibodies, Monoclonal - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Adolescent | Pulmonary Fibrosis - prevention & control | Bone Marrow Transplantation - adverse effects | Vidarabine - administration & dosage | Antibodies, Neoplasm - adverse effects | Epithelial cells | Patient outcomes | Abnormalities | Physiological aspects | Development and progression | Transplantation | Hematopoietic stem cells | Risk factors | Index Medicus
Journal Article
by Boelens, Jaap Jan and Boelens, Jaap Jan and Aldenhoven, Mieke and Aldenhoven, Mieke and Purtill, Duncan and Purtill, Duncan and Ruggeri, Annalisa and Ruggeri, Annalisa and Defor, Todd and DeFor, Todd and Wynn, Robert and Wynn, Robert and Wraith, E and Wraith, Ed and Cavazzana-Calvo, Marina and Cavazzana-Calvo, Marina and Rovelli, Attilio and Rovelli, Attilio and Fischer, Alain and Fischer, Alain and Tolar, Jakub and Tolar, Jakub and Prasad, Vinod K and Prasad, Vinod K and Escolar, Maria and Escolar, Maria and Gluckman, Eliane and Gluckman, Eliane and O'Meara, Anne and O’Meara, Anne and Orchard, Paul J and Orchard, Paul J and Veys, Paul and Veys, Paul and Eapen, Mary and Eapen, Mary and Kurtzberg, Joanne and Kurtzberg, Joanne and Rocha, Vanderson and Rocha, Vanderson and Eurocord, Eurocord and Malech, H and Horwitz, E and Inborn Errors Working Party of European Blood and Marrow Transplant group, Errors Working Party of European Blood and Marrow Transplant group and Le-Rademacher, J and Duke University Blood and Marrow Transplantation Program, University Blood and Marrow Transplantation Program and He, W and Centre for International Blood and Marrow Research, for International Blood and Marrow Research and Gaspar, B and Porta, F and Driscoll, T.A and Landi, D.B and Martin, P.L and Page, K.M and Parikh, H and Ctr Int Blood Marrow Res and Duke Univ and Inborn Errors Working Party of European Blood and Marrow Transplant group and Duke University Blood and Marrow Transplantation Program and Eurocord and Centre for International Blood and Marrow Research and on behalf of all participating centers from Eurocord, Inborn Errors Working Party of European Blood and Marrow Transplant group, Duke University, and the Centre for International Blood and Marrow Research
Blood, ISSN 0006-4971, 05/2013, Volume 121, Issue 19, pp. 3981 - 3987
Journal Article
Lancet Haematology, The, ISSN 2352-3026, 2016, Volume 3, Issue 5, pp. e217 - e227
Summary Background Standard treatment for patients with primary CNS lymphoma remains to be defined. Active therapies are often associated with increased risk... 
Hematology, Oncology and Palliative Medicine | 1ST-LINE TREATMENT | RESPONSE CRITERIA | GUIDELINES | NON-HODGKINS-LYMPHOMA | FOLLOW-UP | CENTRAL-NERVOUS-SYSTEM | WHOLE-BRAIN RADIOTHERAPY | HIGH-DOSE CHEMOTHERAPY | STEM-CELL TRANSPLANTATION | HEMATOLOGY | Follow-Up Studies | Cytarabine - therapeutic use | Humans | Lymphoma, B-Cell - therapy | Middle Aged | Male | Comparative Effectiveness Research | Hyperglycemia - chemically induced | Radiotherapy, Adjuvant - adverse effects | Hematopoietic Stem Cell Transplantation - adverse effects | Lymphoma, B-Cell - diagnostic imaging | Transplantation Conditioning - methods | Rituximab - adverse effects | Induction Chemotherapy - methods | Anemia - chemically induced | Central Nervous System Neoplasms - therapy | Thrombocytopenia - chemically induced | Mucositis - chemically induced | Magnetic Resonance Imaging | Methotrexate - adverse effects | Dexamethasone - therapeutic use | Radiotherapy, Adjuvant - methods | Transplantation, Autologous - adverse effects | Heart Injuries - chemically induced | Italy | Hematopoietic Stem Cell Transplantation - methods | Central Nervous System Neoplasms - mortality | Germany | Thiotepa - adverse effects | Thiotepa - therapeutic use | Thrombosis - chemically induced | Intraocular Lymphoma - therapy | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Cytarabine - adverse effects | Methotrexate - therapeutic use | Infection - chemically induced | Rituximab - therapeutic use | Stroke - chemically induced | Optic Nerve Neoplasms - diagnostic imaging | Poisoning - epidemiology | Female | Remission Induction - methods | Transplantation Conditioning - adverse effects | Acute Kidney Injury - chemically induced | Neutropenia - chemically induced | Optic Nerve Neoplasms - therapy | Death, Sudden - epidemiology | Lymphoma, B-Cell - mortality | Intraocular Lymphoma - diagnostic imaging | Kaplan-Meier Estimate | Chemical and Drug Induced Liver Injury - epidemiology | Treatment Outcome | United Kingdom | Combined Modality Therapy - adverse effects | Switzerland | Induction Chemotherapy - adverse effects | Disease-Free Survival | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Central Nervous System Neoplasms - diagnostic imaging | Denmark | Combined Modality Therapy - methods | Neurotoxicity Syndromes - epidemiology | Gastrointestinal Diseases - chemically induced | Index Medicus
Journal Article
Transplantation, ISSN 0041-1337, 08/2015, Volume 99, Issue 8, pp. 1606 - 1612
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 09/2016, Volume 34, Issue 26, pp. 3141 - 3149
Purpose Related donor haploidentical hematopoietic cell transplantation (Haplo-HCT) using post-transplantation cyclophosphamide (PT-Cy) is increasingly used in... 
DISEASE RISK INDEX | ALLOGENEIC TRANSPLANTATION | HODGKINS-LYMPHOMA | ONCOLOGY | BONE-MARROW | UNRELATED DONORS | IDENTICAL SIBLINGS | PERIPHERAL-BLOOD | UMBILICAL-CORD BLOOD | STEM-CELL TRANSPLANTATION | DOSE POSTTRANSPLANTATION CYCLOPHOSPHAMIDE | Lymphoma - surgery | Multivariate Analysis | Recurrence | Cyclophosphamide - administration & dosage | Humans | Middle Aged | Male | HLA Antigens - genetics | Hematopoietic Stem Cell Transplantation - mortality | Cyclophosphamide - adverse effects | Graft vs Host Disease - immunology | Lymphoma - mortality | Transplantation Conditioning - mortality | Young Adult | Haploidy | Time Factors | Hematopoietic Stem Cell Transplantation - adverse effects | Adult | Female | Registries | Transplantation Conditioning - adverse effects | Transplantation Conditioning - methods | Drug Therapy, Combination | Immunosuppressive Agents - administration & dosage | Siblings | Calcineurin Inhibitors - administration & dosage | Histocompatibility Testing | Graft Rejection - prevention & control | Risk Factors | Lymphoma - immunology | Proportional Hazards Models | HLA Antigens - immunology | Lymphoma - genetics | Treatment Outcome | Disease-Free Survival | Adolescent | Graft vs Host Disease - prevention & control | Immunosuppressive Agents - adverse effects | Aged | Graft Rejection - immunology | Hematopoietic Stem Cell Transplantation - methods | Tissue Donors | Graft Survival - drug effects | Histocompatibility | Index Medicus | Bone2 | ORIGINAL REPORTS
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 03/2008, Volume 26, Issue 9, pp. 1519 - 1525
PURPOSE: The Prospective Oral Mucositis Audit assessed the incidence, duration, and determinants of severe oral mucositis (OM; WHO oral toxicity scale grades 3... 
TRIAL | MULTICENTER | RISK-FACTORS | PALIFERMIN | ONCOLOGY | CONSEQUENCES | ECONOMIC OUTCOMES | COMPLICATIONS | STEM-CELL TRANSPLANTATION | RECIPIENTS | CANCER-THERAPY | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Prospective Studies | Myeloablative Agonists - adverse effects | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Medical Audit | Male | Transplantation, Autologous | Lymphoma, Non-Hodgkin - surgery | Cytarabine - adverse effects | Incidence | Dose-Response Relationship, Drug | Multiple Myeloma - drug therapy | Multiple Myeloma - therapy | Melphalan - adverse effects | Bone Marrow Transplantation | Adult | Female | Stomatitis - epidemiology | Transplantation Conditioning - adverse effects | Transplantation Conditioning - methods | Multiple Myeloma - surgery | Carmustine - adverse effects | Lymphoma, Non-Hodgkin - drug therapy | Etoposide - adverse effects | Risk Assessment | Risk Factors | Europe - epidemiology | Hematopoietic Stem Cell Transplantation | Etoposide - administration & dosage | Cytarabine - administration & dosage | Melphalan - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Lymphoma, Non-Hodgkin - therapy | Stomatitis - chemically induced | Myeloablative Agonists - administration & dosage | Aged | Research Design | Carmustine - administration & dosage | Index Medicus
Journal Article
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 2017, Volume 35, Issue 19, pp. 2157 - 2164
Journal Article
JOURNAL OF CLINICAL ONCOLOGY, ISSN 0732-183X, 04/2017, Volume 35, Issue 11, pp. 1154 - 1161
Journal Article
Journal Article
Journal Article